Trial Profile
Clinical Trial to Compare the Pharmacokinetics Profile of YJAT Sustained Release Tablet and ULTRACET Immediate Release Tablet After Oral Administration to Healthy Male Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 07 May 2021
Price :
$35
*
At a glance
- Drugs Tramadol/paracetamol (Primary)
- Indications Pain
- Focus Pharmacokinetics
- Sponsors Yungjin Pharm Co
- 24 Jun 2013 New trial record